What the GLP-1 Conversation Is Getting Wrong Here is what gets left out: eating disorders are common in the very population most likely to be prescribed GLP-1 medications
John Trojanowski (University of Pennsylvania)
Eli Lilly recently cautioned the public that these medications may contain no medicine, the wrong medicine, incorrect dosages, or multiple medicines mixed together, which could result in serious harm. The illegal use of black market GLP-1 drugs can lead to significant healthcare costs for patientsand for payers
Drink plenty of water throughout the day, too, since dehydration can sneak up when your appetite drops
The reputation of the company in this therapy category, as well as the delivery system, will be the differentiators now, she added, since the underlying semaglutide molecule is the same
Some of the potential risks or drawbacks of semaglutide may include: In general, the medical risks of semaglutide are low, and it is considered a safe medication for most people who need a medical weight loss solution